Walleye Trading LLC Glaukos Corp Call Options Transaction History

Walleye Trading LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$76.4 - $96.33 $244,480 - $308,256	3,200 New	3,200 $301,000
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $186,921 - $213,543	2,700 New	2,700 $203,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $37,472 - $46,792	800 New	800 $43,000
Q2 2022 Aug 08, 2022	SELL	$34.86 - $63.77 $174,300 - $318,850	-5,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $221,650 - $289,100	5,000 New	5,000 $289,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $253,701 - $359,037	-6,300 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $47,430 - $84,230	-1,000 Reduced 13.7%	6,300 $303,000
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $723,294 - $967,230	-9,900 Reduced 57.56%	7,300 $619,000
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $1.14 Million - $1.58 Million	16,200 Added 1620.0%	17,200 $1.44 Million
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $537,900 - $827,860	-11,000 Reduced 91.67%	1,000 $75,000
Q3 2020 Nov 16, 2020	SELL	$37.23 - $50.97 $74,460 - $101,940	-2,000 Reduced 14.29%	12,000 $594,000
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $402,920 - $655,620	14,000 New	14,000 $538,000

345

46.6M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.44B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.